ID   ES-5838
AC   CVCL_6255
SY   5838 Ewing's; 5838; #5838
DR   Cosmic; 1079353
DR   Lonza; 628
DR   Wikidata; Q54832442
RX   PubMed=327080;
RX   PubMed=2620246;
RX   PubMed=3004699;
RX   PubMed=3390826;
RX   PubMed=3518877;
RX   PubMed=6750238;
RX   PubMed=29464090;
RX   PubMed=30879952;
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): PubMed=30879952
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 13
ST   D16S539: 9,11
ST   D3S1358: 16
ST   D5S818: 10
ST   D7S820: 11
ST   FGA: 20,22
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
RX   PubMed=327080; DOI=10.1093/jnci/59.1.221;
RA   Fogh J., Fogh J.M., Orfeo T.;
RT   "One hundred and twenty-seven cultured human tumor cell lines
RT   producing tumors in nude mice.";
RL   J. Natl. Cancer Inst. 59:221-226(1977).
//
RX   PubMed=2620246; DOI=10.3109/07357908909041371;
RA   Gulati S.C., Kwon J.-H., Atzpodien J., Triche T.J., Colvin O.M.,
RA   Clarkson B.D. Sr.;
RT   "In vitro chemosensitivity of two Ewing's sarcoma cell lines:
RT   implication for autologous bone marrow transplantation.";
RL   Cancer Invest. 7:411-416(1989).
//
RX   PubMed=3004699; DOI=10.1016/0165-4608(86)90001-4;
RA   Whang-Peng J., Triche T.J., Knutsen T., Miser J.S., Kao-Shan S.-C.,
RA   Tsai S., Israel M.A.;
RT   "Cytogenetic characterization of selected small round cell tumors of
RT   childhood.";
RL   Cancer Genet. Cytogenet. 21:185-208(1986).
//
RX   PubMed=3390826;
RA   McKeon C., Thiele C.J., Ross R.A., Kwan M., Triche T.J., Miser J.S.,
RA   Israel M.A.;
RT   "Indistinguishable patterns of protooncogene expression in two
RT   distinct but closely related tumors: Ewing's sarcoma and
RT   neuroepithelioma.";
RL   Cancer Res. 48:4307-4311(1988).
//
RX   PubMed=3518877; DOI=10.3109/07357908609038260;
RA   Fogh J.;
RT   "Human tumor lines for cancer research.";
RL   Cancer Invest. 4:157-184(1986).
//
RX   PubMed=6750238;
RA   Dickman P.S., Liotta L.A., Triche T.J.;
RT   "Ewing's sarcoma. Characterization in established cultures and
RT   evidence of its histogenesis.";
RL   Lab. Invest. 47:375-382(1982).
//
RX   PubMed=29464090; DOI=10.18632/oncotarget.23815; PMCID=PMC5814230;
RA   Spurny C., Kailayangiri S., Altvater B., Jamitzky S., Hartmann W.,
RA   Wardelmann E., Ranft A., Dirksen U., Amler S., Hardes J., Fluegge M.,
RA   Meltzer J., Farwick N., Greune L., Rossig C.;
RT   "T cell infiltration into Ewing sarcomas is associated with local
RT   expression of immune-inhibitory HLA-G.";
RL   Oncotarget 9:6536-6549(2018).
//
RX   PubMed=30879952; DOI=10.1016/j.ymthe.2019.02.014; PMCID=PMC6520468;
RA   Kailayangiri S., Altvater B., Lesch S., Balbach S.T., Gottlich C.,
RA   Kuhnemundt J., Mikesch J.-H., Schelhaas S., Jamitzky S., Meltzer J.,
RA   Farwick N., Greune L., Fluegge M., Kerl K., Lode H.N., Siebert N.,
RA   Muller I., Walles H., Hartmann W., Rossig C.;
RT   "EZH2 inhibition in Ewing sarcoma upregulates GD2 expression for
RT   targeting with gene-modified T cells.";
RL   Mol. Ther. 27:933-946(2019).
//